Visual Results of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens
Primary Purpose
Cataract, Presbyopia, Corneal Astigmatism
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Acrysof IQ Vivity Toric Extended Vision Intraocular Lens Implantation
Sponsored by
About this trial
This is an interventional treatment trial for Cataract focused on measuring Extended Vision Intraocular Lens, Toric Intraocular Lens, Visual Outcomes, Rotational Stability, Postoperative Visual Disturbances, Patient Satisfaction, Cataract Surgery
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing uncomplicated cataract surgery with intraocular lens implantation
- Patients motivated by a greater degree of spectacle independence
- Patients possessing with-the-rule astigmatism of ≥ 0.75 diopters (D) or against-the-rule astigmatism of ≥ 0.50 D
- Patients for whom the Barrett Toric Calculator suggests T3-T5 cylinder power AND 15D-25D spherical power in both eyes
- Ability to provide informed consent;
- Ability to be followed for the entire duration of the study.
Exclusion Criteria:
- Ocular comorbidity that might hamper postoperative visual acuity
- Previous refractive surgery
- Expected post-op visual acuity worse than 20/25 (on Snellen chart)
- Refractive lens exchange
- Irregular corneal astigmatism and keratoconus
- Angle Kappa/chord mu ≥ 0.7
- Higher order corneal aberrations > 0.6 root mean square (RMS) units (to exclude irregular corneas)
- Difficulties comprehending written or spoken French or English language
- Patients with physical or intellectual disability (e.g. Down syndrome, Parkinson's disease; unable to fixate)
- Ocular surface disease
- Axial length > 26mm
Sites / Locations
- Centre hospitalier de l'Université de Montréal (CHUM)
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Acrysof IQ Vivity Toric Extended Vision Intraocular Lens Implantation
Arm Description
Outcomes
Primary Outcome Measures
Binocular uncorrected visual acuities for distance (6 meters), intermediate (66 centimeters), and near (40 centimeters)
Evaluation of visual acuity, measured using the Snellen chart.
Secondary Outcome Measures
Mean absolute intraocular lens rotation (subjective)
Mean absolute calculation of intraocular lens rotation compared to axis of placement using slit-lamp measurements (in degrees)
Percentage of toric intraocular lenses within 5 degrees of axis of placement
Percentage calculation using the number of intraocular lens that have rotated within less than 5 degrees of axis of placement using slit-lamp measurements
Postoperative residual astigmatism
Measurement of astigmatism using manifest refraction measurements (in diopters)
Monocular best corrected distance visual acuities (at 6 meters), and distance corrected intermediate (66 centimeters) and near (40 centimeters) visual acuities
Evaluation of visual acuity, measured using the Snellen chart, while correcting refractive error for distance vision only.
Mean refractive spherical equivalent
Calculations of mean refractive spherical equivalent based on manifest refraction measurements (in diopters)
Refractive accuracy
Percentage calculation of the number of eyes with an absolute prediction error of 0.50 diopters or less based on manifest refraction measurements (in diopters)
Patient reported visual disturbances
Evaluation of patient reported visual disturbances using a validated questionnaire for visual disturbances (QUVID)
Full Information
NCT ID
NCT04652037
First Posted
November 23, 2020
Last Updated
December 12, 2022
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
1. Study Identification
Unique Protocol Identification Number
NCT04652037
Brief Title
Visual Results of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens
Official Title
Visual Outcomes and Rotational Stability of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens
Study Type
Interventional
2. Study Status
Record Verification Date
December 2022
Overall Recruitment Status
Completed
Study Start Date
March 17, 2021 (Actual)
Primary Completion Date
September 30, 2022 (Actual)
Study Completion Date
December 5, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The main goal of this study is to evaluate real-world visual outcomes, rotational stability, and patient reported visual disturbances with a non-diffractive extended vision presbyopia and astigmatism correcting intraocular lens in patients with significant corneal astigmatism undergoing bilateral cataract surgery. This is important to ensure optimal results for patients who wish to have intraocular lenses that correct presbyopia and astigmatism, thus giving them a greater independence from spectacles and a better quality of life.
Detailed Description
It is estimated that cataracts are the cause of 33% of visual impairment and 51% of total blindness worldwide. Indeed, they are the most important cause of total blindness and preventable blindness in the world. To reduce the burden of this disease, many advances have been made in the field of cataract surgery and have resulted in better visual outcomes. With the development of different types of intraocular lenses over the years, it is now possible to not only treat cataracts, but also tackle presbyopia and astigmatism to increase patients' independence from spectacles and thus improving quality of life. Indeed, the desire for independence from corrective lenses is an important motivation for many patients, which explains the increasingly common use of intraocular lenses correcting for presbyopia.
For most uncomplicated cataract surgeries today in Quebec, Canada, monofocal lens are implanted and their cost is covered by the government. Generally, this lens allows patients to be emmetropic, which translates to good distance vision. However, these patients will need reading glasses for intermediate and near vision. A good proportion of patients are unsatisfied with being dependent on corrective lenses, especially if they did not have any before surgery. There is a correction technique for presbyopia called "monovision", which involves making the patient's dominant eye emmetropic and making the other eye more myopic. This way, the patient can use the myopic eye for intermediate and near vision. Intermediate vision is useful for computer work, for example, while near vision is useful for reading. "Monovision" requires good tolerance of anisometropia by the patient and may interfere with stereoacuity, which may limit its use.
Multifocal intraocular lenses were first implanted in 1986, but took several years to become more commonly adopted. The terms "bifocal" or "trifocal" refer to the number of distinct foci in the lens, allowing the patient to see at different distances. The simultaneous perception of these multiple focal points can be initially disturbing for the patient and may require several months of postoperative neuroadaptation. There are two types of multifocal lenses: refractive and diffractive lenses. Refractive lenses have concentric rings centrifugally increasing in dioptric power on their anterior surface. Diffractive lenses, on the other hand, have diffractive rings on their posterior portion. Meta-analyses have shown that multifocal lenses cause visual disturbances, such as halos and glare, that are more bothersome and frequent than in "monovision". However, multifocal lenses show better rates of independence from spectacles than "monovision". Refractive multifocal lenses, compared to diffractive lenses, tend to produce more glare, halos and higher-order aberrations. However, refractive lenses tend to produce better uncorrected distance visual acuity, while diffractive lenses tend to perform better for near vision.
Finally, extended depth of focus (EDOF) lenses are a newer technology that will be discussed in this study. They have an extended continuous focal point as opposed to the fixed focal points of multifocal lenses, which allows for less superimposition of near and far images compared to multifocal lenses. Theoretical interferometry studies also suggest that EDOF lenses produce better images in between intermediate and near vision. A few comparative studies have shown that EDOF lenses show equal or poorer near visual acuity than diffractive lenses, but have equal or better results for intermediate visual acuity. There are also other newer types of intraocular lenses that, due to their novelty, lack enough data at this time. These include accommodative lenses, postoperative non-invasively adjustable lenses and electronic lenses.
Astigmatism is a refractive error caused by an irregularity in the cornea and/or the crystalline lens that prevents the eye from focusing light evenly on the retina. It causes blurred vision at all distances. It is estimated that almost two-thirds of patients undergoing cataract surgery have preoperative corneal astigmatism between 0.25 and 1.25 diopters. 22% of these patients have astigmatism of 1.50 diopters or more. Toric intraocular lens implantation, first introduced in 1992, is the procedure of choice to correct significant corneal astigmatism (1.00 diopter or greater). For optimal correction of astigmatism with the toric lens, precise alignment of the actual lens axis with the calculated preoperative lens axis of placement is required. This is influenced by several factors, a major one being the rotational stability of the lens. Maximum rotational stability has been observed with hydrophobic acrylic lenses. A prospective study with AcrySof Toric lenses showed significant postoperative rotation of more than 10 degrees in only 1.68% of eyes. In fact, the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens is made with the same AcrySof material, which has shown excellent postoperative rotational stability.
To our knowledge, no study to this day has evaluated the refractive visual outcomes of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens for the correction of presbyopia and corneal astigmatism. This is believed to be the first study of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens in Canada. Studying the impact of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens will provide real-world data on visual acuities after bilateral cataract surgery, intraocular lens rotational stability and subjective assessment of postoperative visual disturbances. This is important to ensure optimal results for patients who wish to have intraocular lenses that correct presbyopia and astigmatism, thus giving them a greater independence from spectacles and a better quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract, Presbyopia, Corneal Astigmatism
Keywords
Extended Vision Intraocular Lens, Toric Intraocular Lens, Visual Outcomes, Rotational Stability, Postoperative Visual Disturbances, Patient Satisfaction, Cataract Surgery
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Acrysof IQ Vivity Toric Extended Vision Intraocular Lens Implantation
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Acrysof IQ Vivity Toric Extended Vision Intraocular Lens Implantation
Other Intervention Name(s)
DFT315, DFT415, or DFT515 Intraocular Lens Implantation
Intervention Description
Implantation during bilateral cataract surgery of a new non-diffractive extended vision presbyopia and astigmatism correcting intraocular lens (Acrysof IQ Vivity Toric Extended Vision Intraocular Lens)
Primary Outcome Measure Information:
Title
Binocular uncorrected visual acuities for distance (6 meters), intermediate (66 centimeters), and near (40 centimeters)
Description
Evaluation of visual acuity, measured using the Snellen chart.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Mean absolute intraocular lens rotation (subjective)
Description
Mean absolute calculation of intraocular lens rotation compared to axis of placement using slit-lamp measurements (in degrees)
Time Frame
1 day, 1 week, 3 months
Title
Percentage of toric intraocular lenses within 5 degrees of axis of placement
Description
Percentage calculation using the number of intraocular lens that have rotated within less than 5 degrees of axis of placement using slit-lamp measurements
Time Frame
3 months
Title
Postoperative residual astigmatism
Description
Measurement of astigmatism using manifest refraction measurements (in diopters)
Time Frame
3 months
Title
Monocular best corrected distance visual acuities (at 6 meters), and distance corrected intermediate (66 centimeters) and near (40 centimeters) visual acuities
Description
Evaluation of visual acuity, measured using the Snellen chart, while correcting refractive error for distance vision only.
Time Frame
3 months
Title
Mean refractive spherical equivalent
Description
Calculations of mean refractive spherical equivalent based on manifest refraction measurements (in diopters)
Time Frame
3 months
Title
Refractive accuracy
Description
Percentage calculation of the number of eyes with an absolute prediction error of 0.50 diopters or less based on manifest refraction measurements (in diopters)
Time Frame
3 months
Title
Patient reported visual disturbances
Description
Evaluation of patient reported visual disturbances using a validated questionnaire for visual disturbances (QUVID)
Time Frame
3 months
Other Pre-specified Outcome Measures:
Title
Mean absolute intraocular lens rotation (objective)
Description
Mean absolute calculation of intraocular lens rotation compared to axis of placement using measures from the OPD-Scan (in degrees)
Time Frame
1 day, 1 week, 3 months
Title
Mean absolute prediction error
Description
Mean absolute calculation of prediction error based on manifest refraction measurements (in diopters)
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients undergoing uncomplicated cataract surgery with intraocular lens implantation
Patients motivated by a greater degree of spectacle independence
Patients possessing with-the-rule astigmatism of ≥ 0.75 diopters (D) or against-the-rule astigmatism of ≥ 0.50 D
Patients for whom the Barrett Toric Calculator suggests T3-T5 cylinder power AND 15D-25D spherical power in both eyes
Ability to provide informed consent;
Ability to be followed for the entire duration of the study.
Exclusion Criteria:
Ocular comorbidity that might hamper postoperative visual acuity
Previous refractive surgery
Expected post-op visual acuity worse than 20/25 (on Snellen chart)
Refractive lens exchange
Irregular corneal astigmatism and keratoconus
Angle Kappa/chord mu ≥ 0.7
Higher order corneal aberrations > 0.6 root mean square (RMS) units (to exclude irregular corneas)
Difficulties comprehending written or spoken French or English language
Patients with physical or intellectual disability (e.g. Down syndrome, Parkinson's disease; unable to fixate)
Ocular surface disease
Axial length > 26mm
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Georges Durr, MD, FRCSC
Organizational Affiliation
Centre hospitalier de l'Université de Montréal (CHUM)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre hospitalier de l'Université de Montréal (CHUM)
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H2X 3E4
Country
Canada
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
22133988
Citation
Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012 May;96(5):614-8. doi: 10.1136/bjophthalmol-2011-300539. Epub 2011 Dec 1.
Results Reference
background
PubMed Identifier
29032195
Citation
Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR; Vision Loss Expert Group of the Global Burden of Disease Study. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017 Dec;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5. Epub 2017 Oct 11.
Results Reference
background
PubMed Identifier
18090889
Citation
Talley-Rostov A. Patient-centered care and refractive cataract surgery. Curr Opin Ophthalmol. 2008 Jan;19(1):5-9. doi: 10.1097/ICU.0b013e3282f2d7a3.
Results Reference
background
PubMed Identifier
16338569
Citation
Hawker MJ, Madge SN, Baddeley PA, Perry SR. Refractive expectations of patients having cataract surgery. J Cataract Refract Surg. 2005 Oct;31(10):1970-5. doi: 10.1016/j.jcrs.2005.03.065.
Results Reference
background
PubMed Identifier
30993062
Citation
Sieburth R, Chen M. Intraocular lens correction of presbyopia. Taiwan J Ophthalmol. 2019 Jan-Mar;9(1):4-17. doi: 10.4103/tjo.tjo_136_18.
Results Reference
background
PubMed Identifier
3312575
Citation
Keates RH, Pearce JL, Schneider RT. Clinical results of the multifocal lens. J Cataract Refract Surg. 1987 Sep;13(5):557-60. doi: 10.1016/s0886-3350(87)80114-1.
Results Reference
background
PubMed Identifier
28366683
Citation
Alio JL, Plaza-Puche AB, Fernandez-Buenaga R, Pikkel J, Maldonado M. Multifocal intraocular lenses: An overview. Surv Ophthalmol. 2017 Sep-Oct;62(5):611-634. doi: 10.1016/j.survophthal.2017.03.005. Epub 2017 Mar 31.
Results Reference
background
PubMed Identifier
27943250
Citation
de Silva SR, Evans JR, Kirthi V, Ziaei M, Leyland M. Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database Syst Rev. 2016 Dec 12;12(12):CD003169. doi: 10.1002/14651858.CD003169.pub4.
Results Reference
background
PubMed Identifier
25250421
Citation
Xu X, Zhu MM, Zou HD. Refractive versus diffractive multifocal intraocular lenses in cataract surgery: a meta-analysis of randomized controlled trials. J Refract Surg. 2014 Sep;30(9):634-44. doi: 10.3928/1081597X-20140814-04.
Results Reference
background
PubMed Identifier
26948789
Citation
Dominguez-Vicent A, Esteve-Taboada JJ, Del Aguila-Carrasco AJ, Monsalvez-Romin D, Montes-Mico R. In vitro optical quality comparison of 2 trifocal intraocular lenses and 1 progressive multifocal intraocular lens. J Cataract Refract Surg. 2016 Jan;42(1):138-47. doi: 10.1016/j.jcrs.2015.06.040.
Results Reference
background
PubMed Identifier
29634837
Citation
Savini G, Schiano-Lomoriello D, Balducci N, Barboni P. Visual Performance of a New Extended Depth-of-Focus Intraocular Lens Compared to a Distance-Dominant Diffractive Multifocal Intraocular Lens. J Refract Surg. 2018 Apr 1;34(4):228-235. doi: 10.3928/1081597X-20180125-01.
Results Reference
background
PubMed Identifier
30089179
Citation
Cochener B, Boutillier G, Lamard M, Auberger-Zagnoli C. A Comparative Evaluation of a New Generation of Diffractive Trifocal and Extended Depth of Focus Intraocular Lenses. J Refract Surg. 2018 Aug 1;34(8):507-514. doi: 10.3928/1081597X-20180530-02.
Results Reference
background
PubMed Identifier
19101427
Citation
Ferrer-Blasco T, Montes-Mico R, Peixoto-de-Matos SC, Gonzalez-Meijome JM, Cervino A. Prevalence of corneal astigmatism before cataract surgery. J Cataract Refract Surg. 2009 Jan;35(1):70-5. doi: 10.1016/j.jcrs.2008.09.027.
Results Reference
background
PubMed Identifier
7996408
Citation
Shimizu K, Misawa A, Suzuki Y. Toric intraocular lenses: correcting astigmatism while controlling axis shift. J Cataract Refract Surg. 1994 Sep;20(5):523-6. doi: 10.1016/s0886-3350(13)80232-5.
Results Reference
background
PubMed Identifier
29208810
Citation
Kaur M, Shaikh F, Falera R, Titiyal JS. Optimizing outcomes with toric intraocular lenses. Indian J Ophthalmol. 2017 Dec;65(12):1301-1313. doi: 10.4103/ijo.IJO_810_17.
Results Reference
background
PubMed Identifier
25149554
Citation
Miyake T, Kamiya K, Amano R, Iida Y, Tsunehiro S, Shimizu K. Long-term clinical outcomes of toric intraocular lens implantation in cataract cases with preexisting astigmatism. J Cataract Refract Surg. 2014 Oct;40(10):1654-60. doi: 10.1016/j.jcrs.2014.01.044. Epub 2014 Aug 20.
Results Reference
background
Learn more about this trial
Visual Results of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens
We'll reach out to this number within 24 hrs